/term/cash-flow-deferred-tax/XKRX:217950 Pharmaresearch Bio Co (XKRX:217950) Deferred Tax
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaresearch Bio Co Ltd (XKRX:217950) » Definitions » Deferred Tax

Pharmaresearch Bio Co (XKRX:217950) Deferred Tax : ₩2,332 Mil (TTM As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Pharmaresearch Bio Co Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Pharmaresearch Bio Co's change in deferred tax for the six months ended in Dec. 2023 was ₩2,332 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Dec. 2023 was ₩2,332 Mil.

Pharmaresearch Bio Co Deferred Tax Historical Data

The historical data trend for Pharmaresearch Bio Co's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaresearch Bio Co Deferred Tax Chart

Pharmaresearch Bio Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Deferred Tax
Get a 7-Day Free Trial - - - -3,447.24 2,331.97

Pharmaresearch Bio Co Semi-Annual Data
Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Deferred Tax Get a 7-Day Free Trial - - - -3,447.24 2,331.97

Pharmaresearch Bio Co Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2023 was ₩2,332 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmaresearch Bio Co Deferred Tax Related Terms

Thank you for viewing the detailed overview of Pharmaresearch Bio Co's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmaresearch Bio Co (XKRX:217950) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaresearch Bio Co Ltd (XKRX:217950) » Definitions » Deferred Tax
Comparable Companies
XKRX:341170 XKRX:304360 XKRX:378800 XKRX:352770 XKRX:086820 XKRX:244460 XKRX:263050 XKRX:308080 XKRX:288330 XKRX:216400 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
641-3, Saimdang-ro, Gangwon-do, Gangneung-si, KOR, 13494
Website
http://www.pr-bio.co.kr
Pharmaresearch Bio Co Ltd is a Korea-based biopharmaceutical company. The company is engaged in the research and development, manufacturing, sale, and marketing of biopharmaceutical products. Its product is ReNTox Injections, and Clostridium Botulinum Toxin type A is in pipeline.

Pharmaresearch Bio Co (XKRX:217950) Headlines

No Headlines